id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2025-E-0152-0006,FDA,FDA-2025-E-0152,Determination of Regulatory Review Period for Purposes of Patent Extension; COBENFY,Notice,Determinations,2026-02-06T05:00:00Z,2026,2,2026-02-06T05:00:00Z,2026-08-06T03:59:59Z,2026-02-06T20:05:43Z,2026-02388,1,0,09000064b919467e
FDA-2025-E-0152-0005,FDA,FDA-2025-E-0152,Letter to U.S. Patent and Trademark Office,Other,Letter(s),2025-11-24T05:00:00Z,2025,11,2025-11-24T05:00:00Z,,2025-11-25T01:17:54Z,,0,0,09000064b909529e
FDA-2025-E-0152-0004,FDA,FDA-2025-E-0152,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2025-09-11T04:00:00Z,2025,9,2025-09-11T04:00:00Z,,2025-09-11T17:13:08Z,,0,0,09000064b8f5289d
FDA-2025-E-0152-0003,FDA,FDA-2025-E-0152,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2025-08-27T04:00:00Z,2025,8,2025-08-27T04:00:00Z,,2025-08-27T22:15:52Z,,0,0,09000064b8f192d3
FDA-2025-E-0152-0002,FDA,FDA-2025-E-0152,Patent Extension Application from Covington & Burling LLP (on behalf of PureTech Health LLC),Other,Application,2025-01-15T05:00:00Z,2025,1,2025-01-15T05:00:00Z,,2025-01-15T21:08:46Z,,0,0,09000064868bca05
FDA-2025-E-0152-0001,FDA,FDA-2025-E-0152,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2025-01-15T05:00:00Z,2025,1,2025-01-15T05:00:00Z,,2025-11-25T00:15:36Z,,0,0,09000064868bc924